Coronary Artery Disease: Angiolite Stent and Antiplatelet Therapy Study

We are evaluating whether a new stent and a shorter antiplatelet therapy can reduce complications in patients with coronary artery disease. This study compares these approaches to standard treatment options.

>2 years 6-10 visits Confirmation phase (III)No Placebo Partially Remote Standard Medicines OralCardiology

What diseases are being studied?

Health conditions and diseases that the clinical trial is designed to study and treat.

Who can participate in the clinical trial?

These questions help us understand your situation so we can let the trial team know whether you might be a potential match. This is not a medical evaluation and is not part of the official screening, the study doctor will make the final decision..

What medicines are being studied?

Medicines that are officially approved for use in the European Union and considered safe by EMA. These medicines are already on the market and may be tested for new conditions or populations.

Clopidogrel

Clopidogrel is a medicine used to prevent harmful blood clots and reduce the risk of stroke and heart attack.

Prasugrel

Prasugrel is a medicine used to help prevent dangerous blood clots in people with certain heart problems, especially after heart procedures.

Ticagrelor

Ticagrelor is a medicine that helps prevent dangerous blood clots in people after a recent heart attack, chest pain, or certain heart procedures.

What active substances are being studied?

Active substances that are officially approved for use in the European Union and considered safe by EMA. These substances are already on the market and may be tested for new conditions or populations.

Acetylsalicylic Acid

Acetylsalicylic acid is a substance that reduces pain, fever, and inflammation and can help prevent blood clots.

Clopidogrel

Clopidogrel is a substance that helps prevent blood clots by stopping platelets from sticking together, lowering the risk of heart attack and stroke.

Prasugrel

Prasugrel is a substance that prevents blood platelets from clumping, reducing the risk of clots after certain heart procedures.

What similar medicines might you know?

Don't worry if you don't know the medicines tested in the trial. There is a chance you have heard about the similar medicines. Check the list below to see if you are familiar with any of them.

Aclop

Adagrel

Agrelan

Where is the clinical trial being conducted?

Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.

Loading map...

HC Marie Curie

Cardiology

Charleroi, Belgium

CHC MontLegia

Cardiology

Liège, Belgium

CHU Mons University Clinic

Cardiology

Mons, Belgium

Sponsor: Ivascular S.L.

Last updated: Nov 27, 2025

Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.